Endothelial nitric oxide synthase gene G894T polymorphism and myocardial infarction: A meta-analysis of 34 studies involving 21068 subjects

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Luo, Jian Quan ^a   Wen, Jia Gen ^a   Zhou, Hong Hao ^a   Chen, Xiao Ping ^a   Zhang, Wei ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE;

ARTICLE; ASIAN; CAUCASIAN; DNA POLYMORPHISM; DOMINANT INHERITANCE; ENOS GENE; ETHNIC DIFFERENCE; GENETIC ASSOCIATION; GENETIC MODEL; GENETIC RISK; HEART INFARCTION; HOMOZYGOTE; HUMAN; RECESSIVE INHERITANCE; RISK ASSESSMENT; RISK FACTOR; SYSTEMATIC REVIEW;

ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MYOCARDIAL INFARCTION; NITRIC OXIDE SYNTHASE TYPE III; POLYMORPHISM, GENETIC; RISK;

EID: 84900414076     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0087196     Document Type: Article

References (51)

1. Verschuren JJ, Trompet S, Deelen J, Stott DJ, Sattar N, et al. (2013) Nonhomologous end-joining pathway associated with occurrence of myocardial infarction: gene set analysis of genome-wide association study data. PLoS One 8: e56262.
2. Song C, Pedersen NL, Reynolds CA, Sabater-Lleal M, Kanoni S, et al. (2013) Genetic variants from lipid-related pathways and risk for incident myocardial infarction. PLoS One 8: e60454.
3. Gong LL, Peng JH, Han FF, Zhu J, Fang LH, et al. (2012) Association of tissue plasminogen activator and plasminogen activator inhibitor polymorphism with myocardial infarction: a meta-analysis. Thromb Res 130: e43-e51.
4. Franco E, Palumbo L, Crobu F, Anselmino M, Frea S, et al. (2007) Renin-angiotensin-aldosterone system polymorphisms: a role or a hole in occurrence and long-term prognosis of acute myocardial infarction at young age. BMC Med Genet 8: 27.
5. Zhang K, Bai P, Shi S, Zhou B, Wang Y, et al. (2012) The G894T polymorphism on endothelial nitric oxide synthase gene is associated with increased coronary heart disease among Asia population: evidence from a Meta analysis. Thromb Res 130: 192-197.
6. Forstermann U, Munzel T (2006) Endothelial nitric oxide synthase in vascular disease: from marvel to menace. Circulation 113: 1708-1714.
7. Chien YH, Bau DT, Jan KY (2004) Nitric oxide inhibits DNA-adduct excision in nucleotide excision repair. Free Radic Biol Med 36: 1011-1017.
8. Veldman BA, Spiering W, Doevendans PA, Vervoort G, Kroon AA, et al. (2002) The Glu298Asp polymorphism of the NOS 3 gene as a determinant of the baseline production of nitric oxide. J Hypertens 20: 2023-2027. (Pubitemid 35305500)
9. Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327: 557-560. (Pubitemid 37088507)
10. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7: 177-188. (Pubitemid 17189972)
11. Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22: 719-748.
12. Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50: 1088-1101.
13. Egger M, Davey SG, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315: 629-634. (Pubitemid 27387172)
14. Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6: e1000097.
15. Shimasaki Y, Yasue H, Yoshimura M, Nakayama M, Kugiyama K, et al. (1998) Association of the missense Glu298Asp variant of the endothelial nitric oxide synthase gene with myocardial infarction. J Am Coll Cardiol 31: 1506-1510. (Pubitemid 28273291)
16. Hibi K, Ishigami T, Tamura K, Mizushima S, Nyui N, et al. (1998) Endothelial nitric oxide synthase gene polymorphism and acute myocardial infarction. Hypertension 32: 521-526. (Pubitemid 28429143)
17. Cai H, Wang X, Colagiuri S, Wilcken DE (1998) A common Glu298->Asp (894G->T) mutation at exon 7 of the endothelial nitric oxide synthase gene and vascular complications in type 2 diabetes. Diabetes Care 21: 2195-2196. (Pubitemid 28549178)
18. Poirier O, Mao C, Mallet C, Nicaud V, Herrmann SM, et al. (1999) Polymorphisms of the endothelial nitric oxide synthase gene - no consistent association with myocardial infarction in the ECTIM study. Eur J Clin Invest 29: 284-290. (Pubitemid 29188821)
19. Hingorani AD, Liang CF, Fatibene J, Lyon A, Monteith S, et al. (1999) A common variant of the endothelial nitric oxide synthase (Glu298->Asp) is a major risk factor for coronary artery disease in the UK. Circulation 100: 1515-1520. (Pubitemid 29461463)
20. Cai H, Wilcken DE, Wang XL (1999) The Glu-298->Asp (894G->T) mutation at exon 7 of the endothelial nitric oxide synthase gene and coronary artery disease. J Mol Med (Berl) 77: 511-514. (Pubitemid 29372583)
21. Song J (2000) Association study of Alu repeat insertion/deletion polymorphism in tissue plasminogen activator gene and the Glu-Asp298 mutation at exon7 of the endothelial nitric oxide synthase gene with myocardial infarction. Chinese Academy Of Medical Science press 51p.
22. Wang CL, Hsu LA, Ko YS, Ko YL, Lee YH (2001) Lack of association between the Glu298Asp variant of the endothelial nitric oxide synthase gene and the risk of coronary artery disease among Taiwanese. J Formos Med Assoc 100: 736-740.
23. Gardemann A, Lohre J, Cayci S, Katz N, Tillmanns H, et al. (2002) The T allele of the missense Glu(298)Asp endothelial nitric oxide synthase gene polymorphism is associated with coronary heart disease in younger individuals with high atherosclerotic risk profile. Atherosclerosis 160: 167-175. (Pubitemid 34076652)
24. Wei D, Shan J, Chen Z, Shi Y (2002) The G894T mutation of the endothelial nitric oxide synthase gene is associated with coronary atherosclerotic heart disease in Chinese. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 19: 471-474. (Pubitemid 36005212)
25. Aras O, Hanson NQ, Bakanay SM, Tsai MY, Gulec S (2002) Endothelial nitric oxide gene polymorphism (Glu298Asp) is not associated with coronary artery disease in Turkish population. Thromb Haemost 87: 347-349. (Pubitemid 34139881)
26. Qi J, Ma Y, Li M, Yuan D, Zeng D (2003) Endothelial nitric oxide synthase gene polymorphism and acute myocardial infarction. Chinese Journal of Practical Internal Medicine 23: 470-473.
27. Schmoelzer I, Renner W, Paulweber B, Malaimare L, Iglseder B, et al. (2003) Lack of association of the Glu298Asp polymorphism of endothelial nitric oxide synthase with manifest coronary artery disease, carotid atherosclerosis and forearm vascular reactivity in two Austrian populations. Eur J Clin Invest 33: 191-198. (Pubitemid 36411536)
28. Agema WR, de Maat MP, Zwinderman AH, Kastelein JJ, Rabelink TJ, et al. (2004) An integrated evaluation of endothelial constitutive nitric oxide synthase polymorphisms and coronary artery disease in men. Clin Sci (Lond) 107: 255-261. (Pubitemid 39243884)
29. Zhan Y, Di Q, Cheng Y, Ding X (2005) Correlation between Glu298Asp polymorphism of vascular endothelial nitric oxide synthase gene and myocardial infarction in the elderly Chinese. Chinese Journal of Clinical Rehabilitation 9: 177-179. (Pubitemid 40846780)
30. Antoniades C, Tousoulis D, Vasiliadou C, Pitsavos C, Chrysochoou C, et al. (2005) Genetic polymorphism on endothelial nitric oxide synthase affects endothelial activation and inflammatory response during the acute phase of myocardial infarction. J Am Coll Cardiol 46: 1101-1109. (Pubitemid 41316521)
31. Yu H (2006) The relations of gene polymorphisms of eNOS and FVll with Coronary Heart Disease in Henan Han population. Zhengzhou University press 21p.
32. Chao YX (2006) Association of the endothelial nitric oxide synthase gene polymorphism with essential hypertension and its cardiocerebrovascular complications. Shandong University press 35p.
33. Jo I, Moon J, Yoon S, Kim HT, Kim E, et al. (2006) Interaction between - 786TC polymorphism in the endothelial nitric oxide synthase gene and smoking for myocardial infarction in Korean population. Clin Chim Acta 365: 86-92. (Pubitemid 43196420)
34. Sampaio MF, Hirata MH, Hirata RD, Santos FC, Picciotti R, et al. (2007) AMI is associated with polymorphisms in the NOS3 and FGB but not in PAI-1 genes in young adults. Clin Chim Acta 377: 154-162. (Pubitemid 44914068)
35. Andrikopoulos GK, Grammatopoulos DK, Tzeis SE, Zervou SI, Richter DJ, et al. (2008) Association of the 894G.T polymorphism in the endothelial nitric oxide synthase gene with risk of acute myocardial infarction. BMC Med Genet 9: 43.
36. Odeberg J, Larsson CA, Rastam L, Lindblad U (2008) The Asp298 allele of endothelial nitric oxide synthase is a risk factor for myocardial infarction among patients with type 2 diabetes mellitus. BMC Cardiovasc Disord 8: 36.
37. Vasilakou M, Votteas V, Kasparian C, Pantazopoulos N, Dedoussis G, et al. (2008) Lack of association between endothelial nitric oxide synthase gene polymorphisms and risk of premature coronary artery disease in the Greek population. Acta Cardiol 63: 609-614.
38. Gluba A, Banach M, Rysz J, Piotrowski G, Fendler W, et al. (2009) Is polymorphism within eNOS gene associated with the late onset of myocardial infarction? A pilot study. Angiology 60: 588-595.
39. Szabo GV, Kunstar A, Acsady G (2009) Methylentetrahydrofolate reductase and nitric oxide synthase polymorphism in patients with atherosclerosis and diabetes. Pathol Oncol Res 15: 631-637.
40. Isordia-Salas I, Leanos-Miranda A, Borrayo-Sanchez G (2010) The Glu298ASP polymorphism of the endothelial nitric oxide synthase gene is associated with premature ST elevation myocardial infarction in Mexican population. Clin Chim Acta 411: 553-557.
41. Angeline T, Isabel W, Tsongalis GJ (2010) Endothelial nitric oxide gene polymorphisms, nitric oxide production and coronary artery disease risk in a South Indian population. Exp Mol Pathol 89: 205-208.
42. Dafni C, Drakoulis N, Landt O, Panidis D, Reczko M, et al. (2010) Association of the eNOS E298D polymorphism and the risk of myocardial infarction in the Greek population. BMC Med Genet 11: 133.
43. Katakami N, Kaneto H, Matsuoka TA, Takahara M, Imamura K, et al. (2010) Accumulation of gene polymorphisms related to oxidative stress is associated with myocardial infarction in Japanese type 2 diabetic patients. Atherosclerosis 212: 534-538.
44. Gad MZ, Abdel RM, Hashad IM, Abdel-Maksoud SM, Farag NM, et al. (2012) Endothelial nitric oxide synthase (G894T) gene polymorphism in a random sample of the Egyptian population: comparison with myocardial infarction patients. Genet Test Mol Biomarkers 16: 695-700.
45. Zigra AM, Rallidis LS, Anastasiou G, Merkouri E, Gialeraki A (2013) eNOS gene variants and the risk of premature myocardial infarction. Dis Markers 34: 431-436.
46. Narne P, Ponnaluri KC, Singh S, Siraj M, Ishaq M (2013) Association of the genetic variants of endothelial nitric oxide synthase gene with angiographically defined coronary artery disease and myocardial infarction in South Indian patients with type 2 diabetes mellitus. J Diabetes Complications 27: 255-261.
47. Arun KA, Umamaheswaran G, Padmapriya R, Balachandar J, Adithan C (2013) Endothelial nitric oxide synthase gene polymorphisms and the risk of acute myocardial infarction in a South Indian population. Mol Biol Rep 40: 1275-1281.
48. Yoshimura M, Yasue H, Nakayama M, Shimasaki Y, Sumida H, et al. (1998) A missense Glu298Asp variant in the endothelial nitric oxide synthase gene is associated with coronary spasm in the Japanese. Hum Genet 103: 65-69. (Pubitemid 28398388)
49. Niu W, Qi Y (2011) An updated meta-analysis of endothelial nitric oxide synthase gene: three well-characterized polymorphisms with hypertension. PLoS One 6: e24266.
50. Rankinen T, Rice T, Perusse L, Chagnon YC, Gagnon J, et al. (2000) NOS3 Glu298Asp genotype and blood pressure response to endurance training: the HERITAGE family study. Hypertension 36: 885-889.
51. Casas JP, Bautista LE, Humphries SE, Hingorani AD (2004) Endothelial nitric oxide synthase genotype and ischemic heart disease: meta-analysis of 26 studies involving 23028 subjects. Circulation 109: 1359-1365. (Pubitemid 38387821)